Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction. [electronic resource]
Producer: 19990106Description: 1060-8 p. digitalISSN:- 0022-5223
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Cardiopulmonary Bypass -- adverse effects
- Chemotaxis, Leukocyte -- drug effects
- Complement C5a -- immunology
- Coronary Vessels -- drug effects
- Endothelium, Vascular -- drug effects
- Female
- Heart Arrest, Induced -- adverse effects
- Hemodynamics -- drug effects
- Male
- Mice
- Mice, Inbred BALB C
- Myocardial Reperfusion Injury -- enzymology
- Neutrophils -- drug effects
- Nitric Oxide Synthase -- metabolism
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Peroxidase -- metabolism
- Swine
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.